Evidence map›Paper›PMID 35545616›Full record

ArticleNature communications2022

Unlocking the functional potential of polyploid yeasts.

Simone Mozzachiodi, Kristoffer Krogerus, Brian Gibson, Alain Nicolas, Gianni Liti

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Polyploidy: A macromutational force pushing bioeconomic developments.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Review
  4. Isolation and characterization of haploid heterothallic beer yeasts.Applied microbiology and biotechnology · 2025
    Article
  5. Enhancing Protein Content in Wild-TypeJournal of microbiology and biotechnology · 2024
    Article
  6. Review
  7. Article
  8. Practical Approaches for the YeastInternational journal of molecular sciences · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 4 countries.

Simone MozzachiodiUniversité Côte d'Azur, CNRS, INSERM, IRCAN, Nice, France. simone.mozzachiodi@univ-cotedazur.fr.ORCID 0000-0002-0950-8674
Kristoffer KrogerusVTT Technical Research Centre of Finland Ltd, Espoo, Finland.ORCID 0000-0001-7694-8277
Brian GibsonVTT Technical Research Centre of Finland Ltd, Espoo, Finland.
Alain NicolasUniversité Côte d'Azur, CNRS, INSERM, IRCAN, Nice, France.
Gianni LitiUniversité Côte d'Azur, CNRS, INSERM, IRCAN, Nice, France. gianni.liti@unice.fr.ORCID 0000-0002-2318-0775
Centre National de la Recherche Scientifique · FRInstitute of Food Science & Technology · GBVTT Technical Research Centre of Finland · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breeding and domestication have generated widely exploited crops, animals and microbes. However, many Saccharomyces cerevisiae industrial strains have complex polyploid genomes and are sterile, preventing genetic improvement strategies based on breeding. Here, we present a strain improvement approach based on the budding yeasts' property to promote genetic recombination when meiosis is interrupted and cells return-to-mitotic-growth (RTG). We demonstrate that two unrelated sterile industrial strains with complex triploid and tetraploid genomes are RTG-competent and develop a visual screening for easy and high-throughput identification of recombined RTG clones based on colony phenotypes. Sequencing of the evolved clones reveal unprecedented levels of RTG-induced genome-wide recombination. We generate and extensively phenotype a RTG library and identify clones with superior biotechnological traits. Thus, we propose the RTG-framework as a fully non-GMO workflow to rapidly improve industrial yeasts that can be easily brought to the market.

Indexed as

Plant BreedingSaccharomyces cerevisiae ProteinsMeiosisPolyploidySaccharomyces cerevisiaeSaccharomyces cerevisiae Proteins

Identifiers

PMID35545616
PMCPMC9095626
OpenAlexW4280494009

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.